Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.333EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.333EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.333ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.429EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.429ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.429EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.429EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.429ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.429ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.458EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.458EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.458ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.458ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.458EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.458EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.458ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.458ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used